Deutsche Bank’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-174,702
| Closed | -$78.6K | – | 3635 |
|
|
2025
Q1 | $78.6K | Hold |
174,702
| – | – | ﹤0.01% | 3243 |
|
|
2024
Q4 | $87.4K | Buy |
174,702
+115,672
| +196% | +$57.8K | ﹤0.01% | 3278 |
|
|
2024
Q3 | $53.7K | Buy |
59,030
+1,419
| +2% | +$1.29K | ﹤0.01% | 3308 |
|
|
2024
Q2 | $57.6K | Sell |
57,611
-17,288
| -23% | -$17.3K | ﹤0.01% | 3254 |
|
|
2024
Q1 | $111K | Sell |
74,899
-1,496
| -2% | -$2.21K | ﹤0.01% | 3083 |
|
|
2023
Q4 | $83.3K | Sell |
76,395
-2,699
| -3% | -$2.94K | ﹤0.01% | 3255 |
|
|
2023
Q3 | $93.3K | Buy |
79,094
+68,147
| +623% | +$80.4K | ﹤0.01% | 3164 |
|
|
2023
Q2 | $15.4K | Buy |
+10,947
| New | +$15.4K | ﹤0.01% | 3568 |
|
|
2022
Q2 | – | Sell |
-68,085
| Closed | -$105K | – | 4050 |
|
|
2022
Q1 | $105K | Sell |
68,085
-8,076
| -11% | -$12.5K | ﹤0.01% | 3525 |
|
|
2021
Q4 | $187K | Buy |
76,161
+4,026
| +6% | +$9.89K | ﹤0.01% | 3384 |
|
|
2021
Q3 | $182K | Buy |
72,135
+143
| +0.2% | +$361 | ﹤0.01% | 3580 |
|
|
2021
Q2 | $205K | Buy |
+71,992
| New | +$205K | ﹤0.01% | 3733 |
|
|
2020
Q2 | – | Sell |
-33,680
| Closed | -$28K | – | 4211 |
|
|
2020
Q1 | $28K | Sell |
33,680
-2,188
| -6% | -$1.82K | ﹤0.01% | 3710 |
|
|
2019
Q4 | $31K | Buy |
35,868
+7,402
| +26% | +$6.4K | ﹤0.01% | 4006 |
|
|
2019
Q3 | $27K | Sell |
28,466
-5,283
| -16% | -$5.01K | ﹤0.01% | 4055 |
|
|
2019
Q2 | $37K | Sell |
33,749
-110,627
| -77% | -$121K | ﹤0.01% | 4376 |
|
|
2019
Q1 | $187K | Sell |
144,376
-232,474
| -62% | -$301K | ﹤0.01% | 3948 |
|
|
2018
Q4 | $343K | Buy |
376,850
+105,022
| +39% | +$95.6K | ﹤0.01% | 3507 |
|
|
2018
Q3 | $559K | Sell |
271,828
-14,838
| -5% | -$30.5K | ﹤0.01% | 3668 |
|
|
2018
Q2 | $517K | Sell |
286,666
-498,349
| -63% | -$899K | ﹤0.01% | 3764 |
|
|
2018
Q1 | $1.85M | Sell |
785,015
-385,329
| -33% | -$907K | ﹤0.01% | 2895 |
|
|
2017
Q4 | $2.2M | Buy |
1,170,344
+702,824
| +150% | +$1.32M | ﹤0.01% | 2633 |
|
|
2017
Q3 | $1.16M | Buy |
467,520
+253,886
| +119% | +$630K | ﹤0.01% | 2869 |
|
|
2017
Q2 | $587K | Buy |
213,634
+174,783
| +450% | +$480K | ﹤0.01% | 3285 |
|
|
2017
Q1 | $115K | Sell |
38,851
-8,228
| -17% | -$24.4K | ﹤0.01% | 3666 |
|
|
2016
Q4 | $147K | Buy |
47,079
+6,778
| +17% | +$21.2K | ﹤0.01% | 3681 |
|
|
2016
Q3 | $135K | Buy |
40,301
+3,640
| +10% | +$12.2K | ﹤0.01% | 3650 |
|
|
2016
Q2 | $82K | Sell |
36,661
-2,278
| -6% | -$5.1K | ﹤0.01% | 3990 |
|
|
2016
Q1 | $96K | Sell |
38,939
-9,982
| -20% | -$24.6K | ﹤0.01% | 3862 |
|
|
2015
Q4 | $161K | Sell |
48,921
-849
| -2% | -$2.79K | ﹤0.01% | 3666 |
|
|
2015
Q3 | $119K | Sell |
49,770
-55,270
| -53% | -$132K | ﹤0.01% | 3840 |
|
|
2015
Q2 | $307K | Buy |
105,040
+78,431
| +295% | +$229K | ﹤0.01% | 3546 |
|
|
2015
Q1 | $105K | Sell |
26,609
-2,513
| -9% | -$9.92K | ﹤0.01% | 3884 |
|
|
2014
Q4 | $86K | Buy |
29,122
+26,589
| +1,050% | +$78.5K | ﹤0.01% | 4489 |
|
|
2014
Q3 | $6K | Buy |
2,533
+360
| +17% | +$853 | ﹤0.01% | 4872 |
|
|
2014
Q2 | $5K | Sell |
2,173
-31,744
| -94% | -$73K | ﹤0.01% | 5027 |
|
|
2014
Q1 | $89K | Buy |
33,917
+15,803
| +87% | +$41.5K | ﹤0.01% | 4272 |
|
|
2013
Q4 | $52K | Sell |
18,114
-47,586
| -72% | -$137K | ﹤0.01% | 4289 |
|
|
2013
Q3 | $200K | Buy |
65,700
+28,474
| +76% | +$86.7K | ﹤0.01% | 4109 |
|
|
2013
Q2 | $118K | Buy |
+37,226
| New | +$118K | ﹤0.01% | 4117 |
|